Abstract
When brief periods of ischemia precede sustained ischemia, infarct size is markedly limited, a phenomenon known as ischemic preconditioning. The main target for the recent basic research on ischemic preconditioning is to seek how adenosine relates to the infarct size-limiting effect. One possibility is that ischemic preconditioning augments release of adenosine during ischemia and reperfusion. To test this idea, we examined whether ischemic preconditioning activates the enzyme responsible for adenosine release, i.e., 5′-nucleotidase, and tested the cause-effect relationship between activation of 5′-nucleotidase and the infarct size-limiting effect. We found that activation of ecto-5′-nucleotidase plays a crucial role for attenuation of infarct size. Ischemic preconditioning increased ecto-5′-nucleotidase activity and adenosine release during reperfusion. An inhibitor of ecto-5′-nucleotidase blunted the infarct size-limiting effect of ischemic preconditioning. Furthermore, activation of ecto-5′-nucleotidase was attributable to the activation of protein kinase C via α1-adrenoceptor stimulation, because both prazosin and GF109203X (an inhibitor of protein kinase C) blunted the activation of ecto-5′-nucleotidase and thereby attenuated the infarct size-limiting effect. We found the phosphorylation of eeto-5′-nucleotidase due to activation of protein kinase C either by the treatment with phorbol ester or by ischemic preconditioning, suggesting that phosphorylation of this enzyme due to protein kinase C may play a key role for activation of ecto-5′-nucleotidase. We also found that transfection of ecto-5′-nucleotidase in the rat neonatal cardiomyocytes exerts potent cytoprotection against hypoxia and reoxygenation injury. Taken together, we propose potential mechanisms for cardioprotection attributable to activation of ecto-5′-nucleotidase in ischemic preconditioning.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Murry CE, Jennings RB, Reimer KA. 1986. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124–1136.
Li GC, Vasquez JA, Gallagher KP, Lucchesi BR. 1990. Myocardial protection with preconditioning. Circulation 82:609–619.
Murry CE, Richard VJ, Reimer KA, Jennings RB. 1990. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 66:913–931.
Steenbergen CM, Perlman R, London E, Murphy E. 1993. Mechanism of preconditioning lonic alterations. Circ Res 72:112–125.
Deutsch E, Berger M, Kussmaul WG, Hirshfeld KW Jr, Herrmann HC, Laskey W. 1990. Adaptation in ischemia during percutaneous transmural coronary angioplasty. Clinical, hemodynamic, and metabolic features. Circulation 82:2044–2051.
Okazaki Y, Kodama K, Sato H, Kitakaze M, Hirayama A, Mishima M, Hori M, Inoue M. 1993. Attenuation of increased regional oxygen consumption during exercise as a major cause of warm-up phenomenon. J Am Coll Cardiol 21:1597–1604.
Liu GS, Thornton J, Van Winkle DM, Stanley AWH, Olsson RA, Downey JM. 1991. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 84:350–356.
Thornton JD, Liu GS, Olsson RA, Downey JM. 1992. Intravenous pretreatment with A1-selective adenosine analogue protects the heart against infarction. Circulation 85:659–665.
Miura T, Ogawa T, Iwamoto T, Shimamoto K, Iimura O. 1992. Dipyridamole potentiates the myocardial infarct size-limiting effect of ischemic preconditioning. Circulation 86:979–985.
Olafsson B, Forman MB, Puett DIY, Pou A, Cates CU, Friesinger GC, Virmani R. 1987. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon. Circulation 76:1135–1145.
Kitakaze M, Hori M, Takashima S, Sato H, Inoue M, Kamada T. 1993. Ischemic preconditioning increases adenosine release and 5′-nucleotidase activity during myocardial ischemia and reperfusion in dogs. Implication for myocardial salvage. Circulation 87:208–215.
Ktakaze M, Hori M, Morioka T, Minamino T, Takashima S, Sato H, Shinozaki Y, Chujo M, Mori H, Inoue M, Kamada T. 1994. The infarct size-limiting effect of ischemic preconditioning is blunted by inhibition of 5′-nucleotidase activity and attenuation of adenosine release. Circulation 89:1237–1246.
Lloyd HGE, Schrader J. 1987. The importance of the transmethylation pathway for adenosine metabolism in the hearts. In Gerlach E, Becker BF (eds), Topics and Perspectives in Adenosine Research. Berlin/Heidelberg: Springer-Verlag, pp. 199–207.
Sparks NV Jr, Bardengeuer H. 1986. Regulation of adenosine formation by the heart. Circ Res 58:193–201.
Hori M, Kitakaze M. 1991. Adenosine, the heart, and coronary circulation. Hypertension 18:565–574.
Kitakaze M, Hori M, Kamada T. 1993. Role of adenosine and its interaction with alpha adrenoceptor activity in ischemic and reperfusion injury of the myocardium. Cardiovasc Res 27:18–27.
Imai S, Nakazawa M, Imai M, Jin H. 1986. 5′-Nucleotidase inhibitors and the myocardial reactive hyperemia and adenosine content. In Gerlach E, Becker BF (eds), Topics and Perspectives in Adenosine Research. Berlin/Heidelberg: Springer-Verlag, pp. 416–424.
Kitakaze M, Hori M, Takashima S, Iwai K, Sato H, Inoue M, Kitabatake A, Kamada T. 1992. Superoxide dismutase enhances ischemia-induced reactive hyperemic flow and adenosine release in dogs: a role of 5′-nucleotidase activity. Circ Res 71:558–566.
Van Wylen DGL. 1994. Effects of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia. Circulation 89:2283–2289.
Al-Awqati Q. 1995. Regulation of ion channels by ABC transporter that secrete ATP. Science 269:805–806.
Tsuchida A, Liu Y, Liu GS, Cohen MV, Downey JM. 1994. Alpha1-adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase activation. Circ Res 75:576–585.
Kitakaze M, Hori M, Morioka T, Minamino T, Takashima S, Okazaki Y, Node K, Komamura K, Iwakura K, Inoue M, Kamada T. 1995. α1-Adrenoceptor activation increases ectosolic 5′-nucleotidase activity and adenosine release in rat cardiomyocytes by activing protein kinase C. Circulation 91:2226–2234.
Kitakaze M, Node K, Minamino T, Komamura K, Funaya H, Shinozaki Y, Chujo M, Mori H, Inoue M, Hori M, Kamada T. 1996. The role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5′-nucleotidase. Circulation 93:781–791.
Kitakaze M, Hori M, Morioka T, Minamino T, Takashima S, Sato H, Shinozaki Y, Chujo M, Mori H, Inoue M, Kamada T. 1994. Alpha1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5′-nucleotidase activity. J Clin Invest 93:2197–2205.
Banerjee A, Locke-Winter C, Rogers KB, Mitchell MB, Brew EC, Cairns CB, Bensard DD, Harken AH. 1993. Preconditioning against myocardial dysfunction after ischemia and reperfusion by a-adrenergic mechanism. Circ Res 73:656–670.
Kitakaze M, Minamino T, Node K, Komamura K, Inoue M, Hori M, Kamada T. 1996. Activation of ecto-5′-nucleotidase by protein kinase C attenuates irreversible cellular injury due to hypoxia and reoxygenation in rat cardiomyocytes. J Mol Cell Cardiol 28:1945–1955.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Kluwer Academic Publishers
About this chapter
Cite this chapter
Kitakaze, M. et al. (1998). Ecto-5′-Nucleotidase and Cardioprotection. In: Mochizuki, S., Takeda, N., Nagano, M., Dhalla, N.S. (eds) The Ischemic Heart. Progress in Experimental Cardiology, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-0-585-39844-0_35
Download citation
DOI: https://doi.org/10.1007/978-0-585-39844-0_35
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-7923-8105-1
Online ISBN: 978-0-585-39844-0
eBook Packages: Springer Book Archive